Bombay High Court Allows Appeal in Trademark Infringement Case — No Deceptive Similarity Between STIMULIV and STIMULET for Different Pharmaceutical Products. The court held that the mark 'STIMULET' used for an allopathic breast cancer drug does not infringe the registered mark 'STIMULIV' used for Ayurvedic liver medicines due to differences in nature, trade channels, and customers under Section 29(2) of the Trade Marks Act, 1999.
20 Jan 2023The case involves a trademark infringement and passing off dispute between two pharmaceutical companies. The appellant, Corona Remedies Private Limite...





